FC

Finepoint Capital Portfolio holdings

AUM $504M
This Quarter Return
-12.45%
1 Year Return
-3.16%
3 Year Return
+45.14%
5 Year Return
–
10 Year Return
–
AUM
$201M
AUM Growth
+$201M
Cap. Flow
-$49.1M
Cap. Flow %
-24.47%
Top 10 Hldgs %
75.88%
Holding
39
New
2
Increased
12
Reduced
2
Closed
9

Top Buys

1
RVMD icon
Revolution Medicines
RVMD
$11.8M
2
SRPT icon
Sarepta Therapeutics
SRPT
$2.41M
3
ASND icon
Ascendis Pharma
ASND
$2.25M
4
FOLD icon
Amicus Therapeutics
FOLD
$1.99M
5
CYTK icon
Cytokinetics
CYTK
$1.84M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$22M
2
SAGE
Sage Therapeutics
SAGE
$16.8M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
$14.4M
4
CLVT icon
Clarivate
CLVT
$11.9M
5
BHC icon
Bausch Health
BHC
$9.32M

Sector Composition

1 Healthcare 99.35%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MLTX icon
1
MoonLake Immunotherapeutics
MLTX
$3.54B
$18.9M 9.41% 331,416 +29,416 +10% +$1.68M
FOLD icon
2
Amicus Therapeutics
FOLD
$2.34B
$18.1M 9.02% 1,489,025 +163,250 +12% +$1.99M
SRPT icon
3
Sarepta Therapeutics
SRPT
$1.78B
$17.6M 8.78% 145,357 +19,900 +16% +$2.41M
PRTA icon
4
Prothena Corp
PRTA
$441M
$16.9M 8.39% 349,300 +32,000 +10% +$1.54M
GLPG icon
5
Galapagos
GLPG
$2.07B
$15.8M 7.89% 458,659 +51,800 +13% +$1.79M
ASND icon
6
Ascendis Pharma
ASND
$11.8B
$15.3M 7.64% 163,772 +24,000 +17% +$2.25M
SWTX
7
DELISTED
SpringWorks Therapeutics
SWTX
$12.9M 6.41% 556,928 -51,700 -8% -$1.2M
CYTK icon
8
Cytokinetics
CYTK
$4.23B
$12.7M 6.33% 431,693 +62,600 +17% +$1.84M
CERE
9
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$12.3M 6.12% 563,345 +70,800 +14% +$1.55M
RVMD icon
10
Revolution Medicines
RVMD
$7.1B
$11.8M 5.89% +427,000 New +$11.8M
ACAD icon
11
Acadia Pharmaceuticals
ACAD
$4.38B
$11.6M 5.78% 556,553 -290,400 -34% -$6.05M
ARVN icon
12
Arvinas
ARVN
$568M
$9.91M 4.94% 504,700 +93,200 +23% +$1.83M
TVTX icon
13
Travere Therapeutics
TVTX
$1.56B
$8.01M 3.99% 895,821 +134,100 +18% +$1.2M
MORF
14
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$7.45M 3.71% 325,356 +37,800 +13% +$866K
RLAY icon
15
Relay Therapeutics
RLAY
$619M
$7.32M 3.65% 870,870 +169,300 +24% +$1.42M
SLDB icon
16
Solid Biosciences
SLDB
$427M
$2.42M 1.21% 961,251 – –
CLDI icon
17
Calidi Biotherapeutics
CLDI
$8.83M
$416K 0.21% +125,000 New +$416K
AAC.WS
18
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$334K 0.17% 504,706 – –
BTWNW
19
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$304K 0.15% 895,000 – –
CVIIW
20
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$169K 0.08% 548,000 – –
CLDI.WS
21
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$144K 0.07% 655,200 – –
CDAQW
22
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$101K 0.05% 459,906 – –
CCVI.WS
23
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$86.4K 0.04% 540,000 – –
ROSS.WS
24
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$49K 0.02% 439,666 – –
CNDA.WS
25
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$42.6K 0.02% 408,333 – –
1
2